Elixinol Wellness Ltd (ASX: EXL) Share Price and News
Price
$0.019
Movement
0.001 (+5.56%)
as at 7 May - Closed (20 mins delayed)
52 Week Range
$0.015 - $0.048
1 Year Return
-52.5%
Elixinol Wellness Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$3.97 million
P/E Ratio
N/A
Dividend Yield
0.00%
Shares Outstanding
220.82 million
Earnings per share
-0.011
Dividend per share
N/A
Year To Date Return
-57.89%
Earnings Yield
N/A
Franking
-
Share Price
$0.019
Day Change
0.001 (+5.56%)
52 Week Range
$0.015 - $0.048
Yesterday's Close
$0.018
Today's Open
$0.018
Days Range
$0.018 - $0.019
Volume
39,757
Avg. Volume (1 month)
427,775
Turnover
$747
as at 7 May - Closed
Elixinol Wellness Ltd (ASX: EXL)
Latest News
Share Market News
ASX stock of the day: Elixinol Global (ASX:EXL) shares blaze new highs
Share Market News
Here's why ASX cannabis shares are falling today
Share Market News
Elixinol share price edges higher on half year earnings release
How to invest
Should you ever buy into an ASX IPO?
Share Fallers
Why Elixinol Global, National Storage, Qantas, & Vicinity shares are dropping lower
Share Gainers
Why this ASX cannabis share zoomed 9% higher today
Share Market News
Cannabis share Elixinol Global announces asset sales
Share Gainers
Why these 3 ASX cannabis shares are flying high in 2020
Share Fallers
Why cannabis company Elixinol Global is down 25% in just two days
52-Week Lows
Bank of Queensland and these ASX shares just sank to multi-year lows
Share Fallers
Why a2 Milk, Elixinol Global, Estia Health, & McMillan Shakespeare are dropping lower
Record Lows
Why the Elixinol Global share price crashed to a record low today
EXL ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| 30th Apr 2025 2025-04-30T10:10:43 | Quarterly Activities/Appendix 4C Cash Flow Report | YesNo | 10:10am | 14 | 958k |
| 30th Apr 2025 2025-04-30T09:54:03 | Response to ASX Price Query | YesNo | 9:54am | 3 | 703k |
| 15th Apr 2025 2025-04-15T11:32:11 | Notice of Annual General Meeting/Proxy Form | YesNo | 11:32am | 17 | 986k |
| 19th Mar 2025 2025-03-19T09:02:47 | Annual General Meeting Date and Director Nominations | YesNo | 9:02am | 2 | 104k |
| 28th Feb 2025 2025-02-28T10:03:12 | FY24 Results Presentation | YesNo | 10:03am | 14 | 1.5M |
| 28th Feb 2025 2025-02-28T10:02:27 | FY24 Results Announcement | YesNo | 10:02am | 2 | 150k |
| 28th Feb 2025 2025-02-28T10:01:52 | Appendix 4G & Corporate Governance Statement | YesNo | 10:01am | 28 | 727k |
| 28th Feb 2025 2025-02-28T10:00:22 | FY24 Appendix 4E and Annual Report | YesNo | 10:00am | 86 | 728k |
| 31st Jan 2025 2025-01-31T09:13:18 | Quarterly Activities/Appendix 4C Cash Flow Report | YesNo | 9:13am | 14 | 1.1M |
| 8th Jan 2025 2025-01-08T09:32:11 | Notification of cessation of securities - EXL | YesNo | 9:32am | 4 | 14k |
About Elixinol Wellness Ltd
Elixinol Wellness Ltd is engaged in the hemp industry, innovating, marketing, and selling hemp-derived nutraceutical, cosmetic, and food products. It operates in the three operating segments of the Americas, Australia, Rest of the World regions of which key revenue is derived from the Australia segment. The Australia segment includes the results from operations of Elixinol Wellness (Byron Bay) Pty Ltd and The Sustainable Nutrition Group Pty Ltd and its subsidiaries. It derives maximum revenue from Australia.
EXL Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 05 May 2025 | $0.02 | $0.00 | 0.00% | 1,665,999 | $0.02 | $0.02 | $0.02 |
| 02 May 2025 | $0.02 | $0.00 | 0.00% | 1,051,672 | $0.02 | $0.02 | $0.02 |
| 01 May 2025 | $0.02 | $0.00 | 0.00% | 2,114,816 | $0.02 | $0.02 | $0.02 |
| 30 Apr 2025 | $0.02 | $0.00 | 0.00% | 796,542 | $0.02 | $0.02 | $0.02 |
| 29 Apr 2025 | $0.02 | $0.00 | 0.00% | 545,379 | $0.02 | $0.02 | $0.02 |
| 28 Apr 2025 | $0.02 | $-0.01 | -35.71% | 1,205,311 | $0.03 | $0.03 | $0.02 |
| 24 Apr 2025 | $0.03 | $0.00 | 0.00% | 3,247 | $0.03 | $0.03 | $0.03 |
| 23 Apr 2025 | $0.03 | $0.00 | 0.00% | 191 | $0.03 | $0.03 | $0.03 |
| 22 Apr 2025 | $0.03 | $0.00 | 0.00% | 64,029 | $0.03 | $0.03 | $0.03 |
| 17 Apr 2025 | $0.03 | $0.00 | 0.00% | 4,278 | $0.03 | $0.03 | $0.03 |
| 16 Apr 2025 | $0.03 | $0.00 | 0.00% | 1,125 | $0.03 | $0.03 | $0.03 |
| 15 Apr 2025 | $0.03 | $0.00 | 0.00% | 37,165 | $0.03 | $0.03 | $0.03 |
| 14 Apr 2025 | $0.03 | $0.00 | 0.00% | 160,047 | $0.03 | $0.03 | $0.03 |
| 10 Apr 2025 | $0.03 | $0.00 | 0.00% | 296,146 | $0.03 | $0.03 | $0.03 |
| 09 Apr 2025 | $0.03 | $0.00 | 0.00% | 1,539 | $0.03 | $0.03 | $0.03 |
| 08 Apr 2025 | $0.03 | $0.00 | 0.00% | 35,983 | $0.03 | $0.03 | $0.03 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 20 Dec 2024 | David (Dave) Fenlon | Exercise | 938,087 | $37,523 |
Conversion of securities. 58,220 performance rights
|
| 20 Dec 2024 | David (Dave) Fenlon | Issued | 938,087 | $37,523 |
Conversion of securities.
|
| 20 Dec 2024 | Pauline Gately | Exercise | 703,565 | $28,142 |
Conversion of securities.
|
| 20 Dec 2024 | Pauline Gately | Issued | 703,565 | $28,142 |
Conversion of securities.
|
| 18 Dec 2024 | Natalie Butler | Expiry | 36,416 | $1,456 |
As advised by the company. 72,834 performance rights, Lapse
|
| 31 May 2024 | David (Dave) Fenlon | Issued | 3,752,345 | $19,999 |
Director remuneration. 4,218,098 rIGHTS
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr David (Dave) Fenlon | Non-Executive DirectorNon-Executive Chairman | Mar 2022 |
Mr Fenlon has over 30 years of world-wide experience in the FMCG and consumer sectors. He was also previously Non-Executive Chair of Nutritional Growth Solutions. Prior to this, he was Managing Director for Australia and New Zealand at Blackmores Limited (ASX: BKL). David has worked with leading retail brands both in Australia and offshore, with a on strategic planning and business transformation including in key positions with Tesco throughout Europe and Safeway in the UK. David was a member of the Board of Directors for the Special Olympics from May 2017 until June 2019. He is a member of the Risk Committee.
|
| Ms Pauline Therese Gately | Non-Executive Director | Aug 2023 |
Ms Gately is a director who brings a commercial focus to strategy in funding, business development, and strategic transformation having led companies through IPO, business recalibration and mergers and acquisitions. Her Board contributions are also underpinned by senior roles in international investment banking across the Asia Pacific region. She is Chair of the Risk Committee.
|
| Ms Natalie Butler | Non-Executive Director | Mar 2024 |
Ms Butler over a decade of strategic marketing leadership to the table, Natalie has a proven history of growth and innovation on both local and global brands. Having worked closely with the Sustainable Nutrition Group marketing and product teams over the past year, she is uniquely positioned to spearhead future growth opportunities for the Group. As General Manager of Tom Organic, Natalie steered the company to success and direct major global initiatives with renowned brands within the L'Oreal Group.
|
| Ms Melanie Jaye Leydin | Company Secretary | Jul 2024 |
-
|
| Melanie Jaye Leydin | Company Secretary |
-
|
|
| Josephine Lorenz | Group Chief Financial Officer |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Freedom Trader Pty Ltd | 14,692,194 | 6.65% |
| Mr Stuart Reseck & Mrs Nicole Deanne Reseck (Reseck Super Fund A/C) | 13,333,334 | 6.04% |
| Cutter Super Pty Ltd (Cutter Sf A/C) | 12,500,000 | 5.66% |
| HSBC Custody Nominees (Australia) Limited | 10,047,366 | 4.55% |
| Cg Nominees (Australia) Pty Ltd | 9,574,074 | 4.34% |
| UBS Nominees Pty Ltd | 7,838,694 | 3.55% |
| 10 Bolivianos Pty Ltd | 6,011,427 | 2.72% |
| G & A Eshuys Superannuation Pty Ltd (G & A Eshuys S/F A/C) | 4,318,665 | 1.96% |
| Gidgell Pty Ltd (The Jay-Em A/C) | 4,256,887 | 1.93% |
| BNP Paribas Noms Pty Ltd | 4,228,987 | 1.92% |
| Rosedale Super Pty Ltd (Rosedale Super Fund A/C) | 3,343,022 | 1.51% |
| Citicorp Nominees Pty Limited | 2,386,228 | 1.08% |
| Jasforce Pty Ltd (Alex Waislitz Retire A/C) | 2,306,551 | 1.04% |
| Ms Pauline Therese Gately | 2,296,671 | 1.04% |
| Capital Accretion Pty Ltd (The Fortified Value A/C) | 2,233,798 | 1.01% |
| Interdale Pty Ltd (Maple Super A/C) | 2,157,888 | 0.98% |
| Raw With Life Pty Ltd (Benhaim Trading A/C) | 2,111,611 | 0.96% |
| Mr David John Fenlon | 1,563,381 | 0.71% |
| Mr Kieran John O'Brien | 1,562,500 | 0.71% |
| A&N Mcintosh Holdings Pty Ltd (Tiger Investment A/C) | 1,551,196 | 0.70% |